CC-122 Rollover Study

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501855-97-00

Acronym

CA0921000

Enrollment

Registered

2023-06-12

Start date

2023-06-29

Completion date

2025-06-04

Last updated

2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse Large B-Cell Lymphoma., Follicular Lymphoma, Multiple Myeloma

None listed

Sex/Gender

All

Age

18 Years to 64 Years

France, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026